---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-070673"
form_type: "8-K"
ticker: "OVID"
cik: "0001636651"
company_name: "Ovid Therapeutics Inc."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:35:51.495844+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Ovid Therapeutics stockholders elect directors, approve executive compensation, ratify KPMG

## Summary
- Proposal 1: Barbara Duncan and Robert Michael Poole elected to board; For votes 36.7M and 40.2M respectively.
- Proposal 2: Advisory vote on executive compensation approved with 40.5M For, 1.76M Against, 0.01M Abstain.
- Proposal 3: Ratification of KPMG as auditor for FY2024 passed with 57.2M For, 1.29M Against, 9,375 Abstain.
- Broker non-votes totaled 16.2M shares on Proposals 1 and 2.

## SEC filing metadata
- accession: 0000950170-24-070673
- form_type: 8-K
- ticker: OVID
- cik: 0001636651
- company_name: Ovid Therapeutics Inc.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636651/000095017024070673/0000950170-24-070673-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636651/000095017024070673/ovid-20240607.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-070673
- JSON: https://secwatch.observer/filing/0000950170-24-070673.json
- Plain text: https://secwatch.observer/filing/0000950170-24-070673.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.